Country: United Kingdom
Language: English
Source: MHRA (Medicines & Healthcare Products Regulatory Agency)
Dequalinium chloride
Gedeon Richter (UK) Ltd
G01AC05
Dequalinium chloride
10mg
Vaginal tablet
Vaginal
No Controlled Drug Status
Valid as a prescribable product
BNF: 07020200; GTIN: 5391500440348
new article-no.: 380225 / 316944 – old article-no.: 380902 / 310424 – Code: dDDdDdDd – Plant: Rottendorf Format 148 x 330 mm – Font: Helvetica Neue 55 Roman – Font-Size: 9 pt – Creation-Date: 25.11.22 – Version 4 PACKAGE LEAFLET: INFORMATION FOR THE USER FLUOMIZIN® 10 MG VAGINAL TABLETS DEQUALINIUM CHLORIDE WHAT IS IN THIS LEAFLET: 1. What Fluomizin is and what it is used for 2. What you need to know before you use Fluomizin 3. How to use Fluomizin 4. Possible side effects 5. How to store Fluomizin 6. Contents of the pack and other information 1. WHAT FLUOMIZIN IS AND WHAT IT IS USED FOR Dequalinium chloride, the active ingredient in Fluomizin, belongs to the family of anti-infective and antiseptic drugs. Dequalinium chloride is active against the bacteria which cause bacterial vaginosis. Fluomizin is used for the treatment of bacterial vaginosis. It is inserted into the vagina for treatment at the site of infection. 2. WHAT YOU NEED TO KNOW BEFORE YOU USE FLUOMIZIN DO NOT USE FLUOMIZIN: • if you are allergic to the active substance dequalinium chloride or any of the other ingredients of this medicine (listed in section 6). • if you have ulcers on your vagina or cervix. • if you have not yet had your first period. WARNINGS AND PRECAUTIONS Intravaginal use of soaps, spermicides and vaginal douches (vaginal washes) is not recommended during treatment with Fluomizin. As with all vaginal infections, unprotected sexual intercourse du ring treatment with Fluomizin is not re commended. Fluomizin does not reduce the effectiveness of latex condoms. This product may reduce the effectiveness of non-latex condoms or diaphragms. Consequently, you should use alternative methods of contracep - tion for at least 12 hours following the treatment. Do not use Fluomizin within 12 hours before birth to minimize exposure of the newborn to dequalinium ch lori de. Please inform your doctor otherwise. You should stop the treatment during the heavy bleeding period of your menstruation and resume afterwards. You should Read the complete document
1 1.3.1 SUMMARY OF PRODUCT CHARACTERISTICS 2 1 NAME OF THE MEDICINAL PRODUCT Fluomizin 10 mg vaginal tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each vaginal tablet contains 10 mg dequalinium chloride. For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Vaginal tablet The vaginal tablets are white or almost white, oval and biconvex with approximate dimension of length: 19 mm, width: 12 mm, and thickness: 6.3 mm. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Fluomizin 10 mg vaginal tablets are indicated for the treatment of Bacterial vaginosis (see section 4.4) Consideration should be given to official guidance on the appropriate use of antibacterial agents. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology One vaginal tablet daily for six days. The vaginal tablets should be inserted deeply into the vagina in the evenings before retiring. This is best performed in a reclining position with the legs slightly bent. The treatment should be interrupted during menstruation and resumed afterwards. Although relief of discharge and inflammation generally occurs within 24 to 72 hours, the treatment should be continued even when there is no subjective discomfort (itching, discharge, smell) anymore. A treatment less than six days could result in a relapse. Fluomizin contains excipients which do not dissolve completely, such that remains of the tablet are occasionally found in the underwear. This is of no importance for the efficacy of Fluomizin. In rare cases of a very dry vagina, it is possible that the vaginal tablet does not dissolve and is discharged by the vagina as intact tablet. As consequence, the treatment is not optimal. For prevention, the vaginal tablet can be moistened with a drop of water before insertion into a very dry vagina. Patients should use a sanitary towel or panty liner. There is no change in colour of the underwear. _Women more than 55 years and elderly _ 3 There is a lack of data on the efficacy and safety of dequalinium chloride in women above 55 years of age. _ _ _ Read the complete document